This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, France, Ireland, Israel, Lithuania, Malta, New Zealand, Nigeria, Poland, Singapore, South Africa, Tunisia, Turkey, UK.
The drug CILOXAN contains one active pharmaceutical ingredient (API):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| CILOXAN Eye drops, solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CILOXAN Ointment | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| CILOXAN Ophthalmic solution | MPI, US: SPL/Old | FDA, National Drug Code (US) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| S01AE03 | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones | |
| S03AA07 | Ciprofloxacin | S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 1217C, 2480M, 5564W |
| BR | Câmara de Regulação do Mercado de Medicamentos | 500900801176315, 500900803179311 |
| CA | Health Products and Food Branch | 01945270, 02200864 |
| EE | Ravimiamet | 1042827, 1842892 |
| FR | Base de données publique des médicaments | 67901977, 69358697, 69501024 |
| GB | Medicines & Healthcare Products Regulatory Agency | 144958, 161481, 186289, 36867 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-578076301 |
| IE | Health Products Regulatory Authority | 17731 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 2782 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1012609, 1081767, 1082882, 1087567, 1088797, 1090232, 1093348 |
| MT | Medicines Authority | MA1249/01301, MA1249/01302, PI1513/00801A, PI908/23201A |
| NG | Registered Drug Product Database | 04-6343 |
| NZ | Medicines and Medical Devices Safety Authority | 12961, 6703 |
| PL | Rejestru Produktów Leczniczych | 100079607, 100105411, 100293915 |
| SG | Health Sciences Authority | 11265P, 11929P |
| TN | Direction de la Pharmacie et du Médicament | 6643142 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699504440508, 8699504612035 |
| US | FDA, National Drug Code | 0065-0654, 0065-0656 |
| ZA | Health Products Regulatory Authority | 35/15.1/0410, Z/15.1/202 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.